Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Combination anti-HIV antibodies provide sustained virological suppressionNature (London), 2022-06, Vol.606 (7913), p.375-381 [Peer Reviewed Journal]2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply. ;Copyright Nature Publishing Group Jun 9, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04797-9 ;PMID: 35650437Full text available |
|
2 |
Material Type: Article
|
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B CellsCell, 2020-07, Vol.182 (1), p.73-84.e16 [Peer Reviewed Journal]2020 ;Copyright © 2020. Published by Elsevier Inc. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Published by Elsevier Inc. 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.05.025 ;PMID: 32425270Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesNature (London), 2020-12, Vol.588 (7839), p.682-687 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Dec 24-Dec 31, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2852-1 ;PMID: 33045718Full text available |
|
4 |
Material Type: Article
|
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spikeNature (London), 2020-08, Vol.584 (7821), p.450-456 [Peer Reviewed Journal]Copyright Nature Publishing Group Aug 20, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2571-7 ;PMID: 32698192Full text available |
|
5 |
Material Type: Article
|
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktailScience, 2020-08, Vol.369 (6506) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abd0827Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variantsNature (London), 2021-12, Vol.600 (7889), p.530-535 [Peer Reviewed Journal]2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Dec 16, 2021 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04117-7 ;PMID: 34670266Full text available |
|
7 |
Material Type: Article
|
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2Science, 2020-08, Vol.369 (6504) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc6952Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal modelScience, 2020-08, Vol.369 (6506) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc7520Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variantsCell Reports, 2022-05, Vol.39 (7), p.110812-110812, Article 110812 [Peer Reviewed Journal]2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Authors 2022 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2022.110812 ;PMID: 35568025Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117Nature (London), 2015-06, Vol.522 (7557), p.487-491 [Peer Reviewed Journal]COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Jun 25, 2015 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature14411 ;PMID: 25855300 ;CODEN: NATUASFull text available |
|
11 |
Material Type: Article
|
Combination therapy with anti-HIV-1 antibodies maintains viral suppressionNature (London), 2018-09, Vol.561 (7724), p.479-484 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Sep 27, 2018 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-018-0531-2 ;PMID: 30258136Full text available |
|
12 |
Material Type: Article
|
Neutralizing Antibodies against SARS-CoV-2 and Other Human CoronavirusesTrends in Immunology, 2020-05, Vol.41 (5), p.355 [Peer Reviewed Journal]2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/j.it.2020.03.007Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
VRC34-Antibody Lineage Development Reveals How a Required Rare Mutation Shapes the Maturation of a Broad HIV-Neutralizing LineageCell host & microbe, 2020-04, Vol.27 (4), p.531-543.e6 [Peer Reviewed Journal]2020 ;Published by Elsevier Inc. ;ISSN: 1931-3128 ;ISSN: 1934-6069 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2020.01.027 ;PMID: 32130953Full text available |
|
14 |
Material Type: Article
|
Evolution of antibody immunity to SARS-CoV-2Nature (London), 2021-03, Vol.591 (7851), p.639-644 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Mar 25, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03207-w ;PMID: 33461210Full text available |
|
15 |
Material Type: Article
|
Broad dengue neutralization in mosquitoes expressing an engineered antibodyPLoS pathogens, 2020-01, Vol.16 (1), p.e1008103 [Peer Reviewed Journal]2020 Buchman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;2020 Buchman et al 2020 Buchman et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1008103 ;PMID: 31945137Full text available |
|
16 |
Material Type: Article
|
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyCell, 2020-11, Vol.183 (4), p.1024-1042.e21 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.09.037 ;PMID: 32991844Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cowsNature (London), 2017-08, Vol.548 (7665), p.108-111 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Aug 3, 2017 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature23301 ;PMID: 28726771Full text available |
|
18 |
Material Type: Article
|
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralizationProceedings of the National Academy of Sciences - PNAS, 2022-03, Vol.119 (11), p.e2122954119-e2122954119 [Peer Reviewed Journal]Copyright National Academy of Sciences Mar 15, 2022 ;Copyright © 2022 the Author(s). Published by PNAS. 2022 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2122954119 ;PMID: 35238654Full text available |
|
19 |
Material Type: Article
|
Development of an inactivated vaccine candidate for SARS-CoV-2Science, 2020-07, Vol.369 (6499) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc1932Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2Science, 2020-06, Vol.368 (6496) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc2241Digital Resources/Online E-Resources |